NCT03671018 2024-11-29A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin LymphomaHoffmann-La RochePhase 1/2 Active not recruiting422 enrolled